↓ Cooling
Health
🔮 Newsylist predicts: fades by tomorrow medium confidence
Men are injecting sketchy substances in their faces for ‘looksmaxxing.' Doctors are horrified
5sources
5articles
3velocity
-80%since first seen
10h agofirst detected
The reporting (5)
- Looksmaxxing? No, Thank You. Women’s Media Center · 14h ago
- DEEP DIVE: The Complicated And Sordid History Of Looksmaxxing. It’s Not What You Think. The Daily Wire · 14h ago
- The dangers of looksmaxxing: Why young men are risking everything for the perfect face The Citizen · 14h ago
- Video Does 'looksmaxxing' work and can you do it safely? ABC News - Breaking News, Latest News and Videos · 14h ago
- Men are injecting sketchy substances in their faces for ‘looksmaxxing.' Doctors are horrified USA Today · 14h ago broke it first
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Related trends
↓ Cooling
Health
🔮 holds
Everyone's talking about hormone therapy for menopause. Should I be on it?
Hormone replacement therapy use has nearly doubled since 2017 amid new guidelines and widespread public discussion.
↑ Rising
Health
🔮 fades
FDA approves 1st mRNA flu shot, from Moderna
The first mRNA-based influenza vaccine has received federal approval in the United States.
↑ Rising
Health
🔮 holds ✗
DNR Closes Additional Areas of Cunningham Falls State Park Following Second Beaver Attack
Two separate beaver attacks at Cunningham Falls State Park prompt additional closures in Maryland.
↓ Cooling
Health
🔮 fades
GLP-1 Drugs May Have a Hidden Effect on Your Eyes, Study Finds
New safety guidance and a lawsuit spotlight a possible eye‑risk link in popular GLP-1 weight‑loss drugs.
◼ Archived
Health
🔮 holds ✗
Pesticide exposure linked to higher risk of ALS, research finds
New research links occupational pesticide exposure to a significantly heightened risk of motor neuron diseases like ALS.
◼ Archived
Health
🔮 fades ✓
Breast cancer checks missing most women under 50 who are at risk, says study
Study finds NHS breast cancer guidelines miss 95% of high‑risk women under 50, sparking calls for review.